Failure to Honor Legal Guardian’s Medication Decisions and Obtain Valid Psychotropic Consents
Summary
The deficiency involves the facility’s failure to honor a legal guardian’s right to make medication treatment decisions for a resident who was severely cognitively impaired and unable to make his own decisions. The resident was admitted with multiple diagnoses including legal blindness, heart failure, dysphagia, alcohol abuse, and kidney disease, and had a BIMS score of 6/15 indicating severe cognitive impairment. Guardianship paperwork identified two family members as co‑guardians. Despite this, the resident was started on quetiapine 50 mg twice daily via tube for behavior following hospital discharge, based on a hospital discharge summary that noted quetiapine had been started for agitation with good response. A medication informed consent form for quetiapine dated shortly after admission documented verbal consent “on the phone” without listing any name under resident/legal representative, left the reason for the prescription blank, and was signed only by a facility representative. The facility also obtained and implemented orders for clonazepam without clearly documented, valid consent from the co‑guardians and in conflict with one guardian’s stated wishes. A medication informed consent form dated several days after admission documented verbal consent from one guardian for clonazepam 0.25 mg BID for anxiety, with side effects including sedation and drowsiness, and was signed only by an RN. Another consent form dated later listed both guardians’ names for an increased clonazepam dose but did not include a dosage, and again lacked the guardians’ signatures. Progress notes show that clonazepam 0.25 mg BID was ordered by the medical director and later increased to 0.5 mg BID for anxiety due to restlessness and behavioral issues. A behavior note documented that a guardian was initially apprehensive about increasing clonazepam due to concern about sedation but, after discussion about the care plan and behaviors, stated they would follow the doctor’s recommendations and that a psychotropic consent was signed and filed, although the form itself did not contain the guardians’ signatures. Interviews with the co‑guardians and staff further demonstrated inconsistencies and lack of reliable consent practices. The co‑guardians stated they were clear that they did not want the resident sedated and specifically did not consent to quetiapine or clonazepam, and that they were not contacted on the dates the facility documented consents for these medications. One guardian reported telling the facility at a care conference that he did not want the resident sedated or “drugged,” while the SSD stated the guardians did not mention not wanting psychotropic medications. RN C reported he obtained verbal consent from one guardian for clonazepam but acknowledged the other guardian opposed the medication and that he entered a late progress note about the consent at the DON’s direction weeks later. RN F reported he completed the consent form for the clonazepam dose increase and that the guardian was reluctant due to fear of sedation. The DON stated that verbal consents were documented on forms and that physical signatures were not obtained because the guardians did not visit often, and confirmed that once verbal consent was obtained, they did not pursue physical signatures. The visitor log showed the guardians did visit on at least two dates during the relevant period, but no signed consents from them were present in the record.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



